Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Ginkgo Bioworks
Ginkgo Bioworks is a biotechnology firm that designs, engineers, develops, tests, and licenses organisms.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Varigen
Terra Bioforge is a biotechnology company that develops new technologies for capturing and expressing natural product pathways.
Sector
Subsector
Location
total rounds
total raised
Granatum Bioworks
Granatum Bioworks is a budget-friendly platform that helps bring biosynthetic products to market.
Sector
Subsector
Location
total rounds
total raised
Bactobio
Bactobio uses breakthrough technologies to discover novel microbes for medical and industrial applications.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds3
Number of Funding Rounds
Money Raised
Their latest funding was raised on 24.05.2023. Their latest investor Radicle Growth. Their latest round Series A
Illumina Ventures
Illumina Ventures is a venture capital firm that invests in early-stage companies in the healthcare and life sciences sectors.
Sector
Subsector
Location
count Of Investments
count Of Exists
RA Capital Management
RA Capital Management is a Boston-based investment advisor that specializes in the life-sciences and drug development sectors.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Better Ventures
Better Ventures funds and supports technology startups that solve big global problems.
Sector
Subsector
Location
count Of Investments
count Of Exists
Co-Investors
Investors13
Number of lead investors
Number of investors
Radicle Growth
Radicle Growth is a San Diego-based accelerator and venture capital firm focused on early-stage ag and food tech startups.
Sector
Subsector
Keywords
Location
count Of Investments
RA Capital Management
RA Capital Management is a Boston-based investment advisor that specializes in the life-sciences and drug development sectors.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Michael Gillespie
Dr. Michael Gillespie serves as an Analyst at RA Capital Management. He serves as Board Member at Pluton Biosciences. His primary responsibilities at RA Capital are to work closely with the Investment Team to originate conviction in potential investments by identifying breakthroughs and putting data into context, as well as advising RA's portfolio companies on many aspects of program and pipeline strategy. His previous experience includes venture development at Health Wildcatters Seed Accelerator and product development in various roles at the Institute for Environmental and Exercise Medicine and as an Aerospace Medicine Clerk at NASA. He holds a BS in Exercise Science from Brigham Young University and an MD from the University of Texas Southwestern School of Medicine.
Grantham Foundation
The Grantham Foundation promotes environmental health by supporting individuals and organizations and emphasizing climate change.
Sector
Subsector
Keywords
Location
count Of Investments
People
Founders3
Barry Goldman
Barry Goldman is a Chief Science Officer, Dr. Goldman develops a scientific strategy for the next generation of microbial discovery at Pluton. He is a results-driven genomic scientist and entrepreneur with a passion for developing innovative, self-directed people and teams that deliver superior results. Prior to founding Pluton, Dr. Goldman led the microbial testing pipeline for Indigo Ag and served as the Microbial Discovery Lead for Monsanto Company. He has published over 30 peer-reviewed studies and is an inventor on more than 10 patents. He earned a Bachelor of Science degree in Botany from the University of Washington and holds a Ph.D. in Microbiology from the University of Utah.
organization founded
Barry Goldman
Ann Guggisberg
Dr. Guggisberg designs and manages research approaches and processes for Micromining®, Pluton’s discovery platform. She co-led Pluton’s proof-of-concept discovery of novel larvicidal bacteria. Dr. Guggisberg brings to Pluton more than 10 years of experience in genetics, biochemistry, and microbiology research.
current job
organization founded
Ann Guggisberg
Steve Slater
Dr. Steven Slater is Vice President of Strategic Initiatives at Terramera. He earned his Ph.D. in Molecular Microbiology from Case Western Reserve University in 1993 and was a NIH Postdoctoral Fellow at Harvard University through 1995. He joined Monsanto in 1996 and held a variety of senior science positions, being appointed as a Monsanto Fellow in 2002. In 2004, he left Monsanto for a tenured faculty position at Arizona State University (ASU) in Tempe, AZ. After nearly five years at ASU, he moved to the University of Wisconsin, where he led scientific programs for six years at the Great Lakes Bioenergy Research Center, a $25M/year DOE-funded program focused on production of cellulosic biofuels. In 2013, he joined Midwestern BioAg as Vice President for Research and Development, and in 2017 he joined Terramera. He remains a scientific advisor to Midwestern BioAg and several other agricultural focused companies.
current job
organization founded
Steve Slater
